Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Jan;26(3):257-71.
doi: 10.1007/s00281-004-0176-0. Epub 2004 Dec 3.

Pathways for antigen cross presentation

Affiliations
Review

Pathways for antigen cross presentation

Pierre Guermonprez et al. Springer Semin Immunopathol. 2005 Jan.

Abstract

Dendritic cells (DCs) have the unique ability to capture cellular tissue antigens, and to present them on MHC class I molecules to antigen-specific CD8(+) T lymphocytes after migration to the draining lymph nodes. This process, called "cross presentation" can lead either to the tolerization or activation of antigen-specific CD8(+) T cells. Antigen capture is believed to occur by phagocytosis of antigen-bearing dead cells. Recent studies suggest that the antigen transferred from the phagocytosed cell to the DC during cross presentation is a proteasome substrate, rather than a proteasomal degradation product. In most cases, the formation of the peptide-MHC class I complexes in DCs requires the export of protein antigens from phagosomes to the cytosol, where they undergo proteasomal degradation. The resulting peptides are then translocated by TAP to the lumen of a cross presentation-loading compartment, for association to MHC class I under the control of chaperones and oxido-reductases. This loading compartment may be either the endoplasmic reticulum (ER) or a mix phagosome-ER compartment. MHC class I egress from the loading compartment to cell surface remains to be analyzed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Curr Opin Cell Biol. 2004 Aug;16(4):422-8 - PubMed
    1. Immunol Rev. 2004 Jun;199:9-26 - PubMed
    1. Eur J Immunol. 2002 Mar;32(3):818-25 - PubMed
    1. Nature. 2000 Sep 14;407(6801):153-9 - PubMed
    1. Nature. 2002 May 9;417(6885):182-7 - PubMed

Substances

LinkOut - more resources